— Conference call to be held Monday, July 13th at 8:00 a.m. E.T. –WALTHAM, Mass., July 10, 2026 /PRNewswire/ — Q32 Bio Inc. (Nasdaq: QTTB) ("Q32 Bio"), a clinical stage biotechnology company focused on developing innovative therapies for…

Read the full release →

News provided by PR Newswire.